|
||||||||||||||||||||||
![]() |
|
![]() |
![]() |
|
![]() tetanus peptide melanoma vaccine A vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus) ![]()
![]() ![]() ![]() |
![]() |
![]() |
![]() |
![]() |
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
![]() A Service of the National Cancer Institute |
![]() |
![]() |